Drug repositioning ...
 
Notifications
Clear all

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer

1 Posts
1 Users
0 Likes
814 Views
Daniel
(@daniel)
Admin
Joined: 7 years ago
Posts: 1156
Topic starter  

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641118/

Also read this  https://www.cancertreatmentsresearch.com/bisphosphonates/ and this  https://www.cancertreatmentsresearch.com/reduce-cholesterol-in-cancer-cells-to-fight-cancer/


   
Quote
Share: